- Home
- SGHC vs NARI Comparison
SGHC vs NARI Comparison
Compare SGHC & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHC
- NARI
- Stock Information
- Founded
- SGHC 2020
- NARI 2011
- Country
- SGHC Guernsey
- NARI United States
- Employees
- SGHC N/A
- NARI N/A
- Industry
- SGHC Services-Misc. Amusement & Recreation
- NARI Medical/Dental Instruments
- Sector
- SGHC Consumer Discretionary
- NARI Health Care
- Exchange
- SGHC Nasdaq
- NARI Nasdaq
- Market Cap
- SGHC 4.2B
- NARI 4.7B
- IPO Year
- SGHC N/A
- NARI 2020
- Fundamental
- Price
- SGHC $7.90
- NARI N/A
- Analyst Decision
- SGHC Strong Buy
- NARI Hold
- Analyst Count
- SGHC 4
- NARI 12
- Target Price
- SGHC $10.00
- NARI $69.22
- AVG Volume (30 Days)
- SGHC 967.5K
- NARI 1.2M
- Earning Date
- SGHC 02-25-2025
- NARI 03-03-2025
- Dividend Yield
- SGHC 3.16%
- NARI N/A
- EPS Growth
- SGHC N/A
- NARI N/A
- EPS
- SGHC 0.01
- NARI N/A
- Revenue
- SGHC $1,736,303,814.00
- NARI $574,498,000.00
- Revenue This Year
- SGHC $18.44
- NARI $24.62
- Revenue Next Year
- SGHC $8.76
- NARI $18.00
- P/E Ratio
- SGHC $878.18
- NARI N/A
- Revenue Growth
- SGHC 10.78
- NARI 22.41
- 52 Week Low
- SGHC $2.90
- NARI $36.73
- 52 Week High
- SGHC $8.51
- NARI $79.99
- Technical
- Relative Strength Index (RSI)
- SGHC 53.92
- NARI 5.14
- Support Level
- SGHC $8.21
- NARI $79.76
- Resistance Level
- SGHC $8.51
- NARI $79.99
- Average True Range (ATR)
- SGHC 0.28
- NARI 0.07
- MACD
- SGHC -0.09
- NARI -5.93
- Stochastic Oscillator
- SGHC 23.75
- NARI 0.00
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.